Compounding plays a critical role in treating and preventing disease when commercially available medicine is unsuitable. USP has developed standards for compounding practitioners since 1820, and presently provides three types of standards to help ensure quality compounded medicines.
For the first time in more than 20 years, U.S. regulators are considering the reintroduction of bovine (cow-derived) heparin into the U.S., helping to address concerns about potential shortages and adulteration issues associated with this widely-used drug.
Developing documentary standards and Reference Standards is the core of what we do at USP. These standards help to assess the quality, strength, identity, and purity of chemical medicines, food chemicals and ingredients, dietary supplements, and biologics, among other items.
The FDA has given the food industry up to three years to remove partially hydrogenated oils (PHOs) from the human food supply. In recent years, fully hydrogenated oils and fats (FHOs) have been used as an alternative to PHOs but there are no public monographs with definitions of FHOs to help ensure buyers that ingredients meet prescribed measures for composition and purity.
India is a prominent player in today’s global pharmaceutical arena and a major contributor to the world’s supply of medicines. A large number of generics and OTC medicines in the U.S. are imported from India, which makes USP's collaborations with Indian pharma critical.